Search

An effort to develop a radiation test after 9/11 inspires a trip through medical history.

… Wednesday, September 7, 2016 Summary Efforts to understand the effect of radiation on healthy tissues and cancer in the body have a long history. An MSK doctor was inspired to explore that history after helping to develop a test to detect radiation exposure. Highlights Simple blood tests to assess radiation

Learn what bladder cancer symptoms can mean in men and women.

… Wednesday, October 26, 2022 Bladder cancer does not affect men and women in the same ways. Knowing the warning signs of bladder cancer can lead to early diagnosis, which greatly improves outcomes. Bladder cancer is the sixth most common cancer in the United States. But there are differences between men

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

… Wednesday, March 13, 2013 Summary Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells. Scientists from Memorial Sloan Kettering have discovered

Learn about research on lymphedema at Memorial Sloan Kettering Cancer Center, which finds that Black and Hispanic women are at highest risk.

… Wednesday, April 3, 2024 Update: Dr Andrea Barrio and colleagues from MSK published a study in JAMA Network in March 2024, which found that Black, Hispanic, and Asian women with breast cancer experience more arm symptoms and worse quality of life than white women after axillary lymph node dissection,

Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.

… Sunday, April 2, 2017 Summary Neratinib,  an experimental drug developed to target certain mutations that drive cancer growth, is showing promise for treating several types of cancer. The findings from a phase II study were presented at the 2017 AACR Annual Meeting . Highlights Basket trials are based

New findings could lead to a different kind of cancer drug that targets a DNA damage repair pathway called nucleotide excision repair.

… Monday, January 11, 2021 Summary A study has uncovered new findings about a DNA repair pathway called nucleotide excision repair and its role in the development of cancer. The paper also details how this defective pathway could be targeted with drugs. Memorial Sloan Kettering scientists have discovered

Learn more about DeepHeme, an artificial intelligence tool that helps doctors to diagnose blood and bone marrow cancers.

… Wednesday, June 11, 2025 Researchers at Memorial Sloan Kettering Cancer Center (MSK), the University of California, San Francisco (UCSF), and University of California, Berkeley (UC Berkeley) have developed an artificial intelligence (AI) tool called DeepHeme that can help automate the diagnosis of blood

Researchers have found that more than 20% of people with a type of cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations.

… Thursday, September 6, 2018 Summary Research conducted at MSK has shown that more than 20% of people with a type of kidney cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations. This number is much higher than expected. Kidney cancer , also

The global clinical research community is facing a clear imperative to move beyond traditional manual data management methods in order to improve data capture, integrity, and exchange, while pursuing other related efficiencies.

… Tuesday, January 14, 2025 The global clinical research community is facing a clear imperative to move beyond traditional manual data management methods in order to improve data capture, integrity, and exchange, while pursuing other related efficiencies. Memorial Sloan Kettering Cancer Center (MSK) has

Vivian Strong, MD, FACS, the Iris Cantor Chair, addressed colleagues and gastric cancer experts from around the world at the International Gastric Cancer Congress 2022.

… Wednesday, March 30, 2022 Vivian Strong, MD, FACS , the Iris Cantor Chair, addressed colleagues and gastric cancer experts from around the world at the International Gastric Cancer Congress 2022 . Dr. Strong presented “Highlights of What is New in Surgery for Gastric Cancer” as part of the meeting’s